36th Annual Scientific Congress of Malaysian Oncological Society

26th-28th September 2025  |  Persada Johor International Convention Centre
26-28 Sept 2025
Persada Johor International Convention Centre

Daily Programme

  1. Home
  2. Programme
  3. Daily Programme

Daily Programme

If you are using mobile devices, please swipe to the right to view the full content

Demystifying Cancer Genomics: A Practical Workshop for Clinicians

THURSDAY, 25 SEPTEMBER 2025

2:00 PM-5:30 PM @ AMARI Hotel Johor Bahru

Only for Delegates who Have Registered For the Workshop

TIME TOPICS
1400 - 1730 Demystifying Cancer Genomics: A Practical Workshop for Clinicians
1400 - 1410 Welcome & Workshop Overview
Moderator: Adj Prof Dr Voon Pei Jye
1410 - 1435 Essentials of NGS in Oncology - Fundamentals & Clinical Relevance
Dr Francis Tieng Yew Fu
1435 - 1500 NGS Techniques
Mr Sayyidi Hamzi
1500 - 1515 Break
1515 - 1540 Interpreting NGS Reports & Clinical Decision-Making
Dr Venkata Pradeep Babu Koyyala
1540 - 1605 Immunogenomics & Precision Immunotherapy in Oncology
Dr Roziana Ariffin
1605 - 1630 Challenges & Pitfalls in Oncology NGS
Prof Dr Tony Lim Kiat Hon
1630 - 1730 Molecular Tumour Board
Panel Discussion : Real-World Insights
Case-Based Learning: Live Interpretation of NGS Report

FRIDAY, 26 September 2025

MOS Members Lounge

MOS Members Lounge will be opened from 0900-1700

TIME BALLROOM 1
Room 301		 BALLROOM 2
 Room 302
 BALLROOM 3
Room 303
0800 onwards REGISTRATION
0900 - 1030 Plenary Session 1: Democratising Cancer Care: Closing the Global Oncology Gap
Chairpersons: Dr Vaishnavi Jeyasingam & Dr Flora Chong Li Tze
0900 - 0920 Addressing Inequities in Access to New Drugs and Clinical Trials by NPRA
Dr Zaril Harza Zakaria
0920 - 0940 Democratising Cancer Care: Closing the Global Oncology Gap, Malaysia Perspective
Dr Ros Suzanna Ahmad Bustamam
0940 - 1000 Democratising Cancer Care: Closing the Global Oncology Gap, Learning from the Experience
Prof Dr C.S. Pramesh
1000 - 1030 Forum Discussion
1030 - 1050 Break
1050 - 1130 OPENING CEREMONY
1130 - 1230 Keynote Address: Thriving Beyond Cancer; Empowering Survivor for a Healthier Future
Chairpersons: Dr Fong Chin Heng & Dr Azura Deniel
1130 - 1150 Comprehensive Survivorship Care Plans
Dr Mothi Babu Ramalingam
1150 - 1210 Financial Toxicity of Cancer in Asian Setting
Prof Dr Nirmala Bhoo Pathy
1210 - 1230 Workplace Reintegration
Dr Nik Khairol Reza Md Yazin
1230 - 1300 Break
1300-1400

Lunch Symposium by AstraZeneca

Perioperative Treatment Strategy for GC / GEJC: Incorporating Immunotherapy

Chairperson:
Dr Ang Soo Fan

Speakers:
Dr Shaheenah Dawood,
Consultant Medical Oncologist,
Mediclinic City Hospital Dubai
Associate Professor of Clinical Oncology,

Mohammed Bin Rashid,
University of Medicine and Health Sciences

Panelist:
Dr Jennifer Leong, Dr Hans Alexander

Lunch Symposium by Pfizer

ALK+ NSCLC Revolution: How Far Have We Come and Where Are We Going?

Chairperson:
Adj Prof Dr Voon Pei Jye

Speakers:
Prof Geoffrey Liu,
Professor of Medicine, Princess Margaret Cancer Centre, Toronto

Dr Katherine Teh, Consultant Clinical Oncologist, Gleneagles Medini Hospital, Johor

Lunch Symposium by BMS

Navigating Complexity to Improve Outcomes in HCC

Chairperson:
Prof Dr Ho Gwo Fuang

Speaker:
Clin Assoc Prof Dr David Tai

 

TIME BALLROOM 1
Room 301		 BALLROOM 2
 Room 302
 BALLROOM 3
Room 303		 Onco Exchange Foyer, Level 3 Onco Exchange Foyer, Level 3
1400 - 1530 Lower GI
Chairpersons:
Dr Eznal Izwadi Mohd Mahidin & Dr Ooi Po Lin
 Early Lung
Chairpersons:
Dr Norhidayu Salimin & Dr Tan Ai Lian		 Dialog Session: Cancer Support Group
Chairperson:
Dato' Dr Mohamed Ibrahim A. Wahid & Dr Natasha Mohd Hashim		 Onco Exchange 1.1: Breast Cancer
1415 - 1515

Chairperson:
Dr Peter Low Qin Jian

Speaker:
Dr Dejan Juric		 Onco Exchange 1.2: Gynae
1415 - 1515

Chairperson:
Dr Rangasamy Ramachandran

Panel:
Clin Asst Prof Chan Junjie Jack, Asst Prof Dr Raviteja Miriyala
1400 - 1410 Evolving Surgical Approaches in Rectal Cancer
Dr Muhammad Ash-Shafhawi Adznan		 Surgical Consensus Key Statement Recommendations for Early Stage Resectable NSCLC
Prof Dr Anand Sachithanandan		 iCARE Cancer Support Association Johor Bahru Introduction
Ms Sim Lin Tyng
1410 - 1420 The Breast Cancer Support Group Johor Bahru Introduction
Datin Ang Chin Fan
1420 - 1430 Optimal Approach to Oligometastatic Colorectal Ca
Dr Nur Fadhlina Abdul Satar		 Advancements in Early Detection Techniques
Dr Aida Abdul Aziz		 Palliative Care Association of Johor Bahru (PCAJB) Introduction
Ms Premala Ponnusamy
1430 - 1440 Yayasan Kanser Tunku Laksamana Johor Introduction
Dr Mohd Roslan Haron
1440 - 1450 mCRC: Year in Review
Dr Ramya Venkateswaran		 Challenges in Diagnosing Early-Stage Lung Cancer
Dr Ng Khai Lip		 CAN-CARE Health Systems Sdn Bhd Introduction
Ms Maria Khong
1450 - 1500 PERKESO Introduction
Mr Aizuddin Mohamed Mansor
1500 - 1520 MDT Discussion Between Colorectal Surgeon and Oncologists The Expanding Role of Immunotherapy and TKI in Early Lung Cancer
Dr Daniel Chan Boon Yeow		 Dialog Session
1520 - 1530 Q&A Q&A    
1530 - 1615

TEA SYMPOSIUM BY Beigene

Checkpoint Inhibitors in Nasopharyngeal Carcinoma (NPC): Evolving Treatment Landscape in NPC

Chairperson:
Prof Dr Wan Zamaniah Wan Ishak,
University Malaya Medical Centre

Speaker:
Prof Dr Virote Sriuranpong,
King Chulalongkorn Memorial Hospital, Chulalongkorn University

Case Presenter:
Dr Ang Choon Seong,
Hospital Umum Sarawak

TEA SYMPOSIUM BY Johnson & Johnson

Redefining the Treatment Landscape for Advanced EGFRm NSCLC

Chairperson:
Dr Lim Chun Sen

Speaker:
Adj Prof Dr Voon Pei Jye,Sarawak General Hospital, Kuching

Dr Daniel Chan Boon Yeow, Senior Consultant, Specialist in Medical Oncology
MBBS (Hons), MRCP (UK), FAMS (Medical Oncology), FRCP (UK)
Medical Oncologist, ICON Medical Centre, Singapore

Sessions taking place in
Ballroom 1 & 2

 

TIME BALLROOM 1
Room 301		 BALLROOM 2
 Room 302
 BALLROOM 3
Room 303
1615 - 1635 Break
1635 - 1725 Upper GI
Chairpersons:
Dr Jenson Sow Wen Jen & Dr Tun Mohd Azlan Mohamed Nor
 Advanced Lung
Chairpersons:
Dr Lim Chun Sen & Adj Prof Dr Voon Pei Jye		 Wellness and Nutrition in Cancer Care
Chairpersons:
Dr Ahmad Naufal Md Alwi & Dr Nurul Iman Fathi
1635 - 1655 Challenges in Managing Potentially Resectable Gastric Cancers
Dr Hans Alexander Mahendran		 Systemic Treatment for Brain Metastases in Lung Cancer
Assoc Prof Dr Tho Lye Mun		 Nutrition: Can I Eat That? Nutrition for Cancer Patients
Dr Nur Hana Hamzaid
1655 - 1715 New Frontier of Locally Advanced Gastic/ GEJ Cancer
Assoc Prof Dr Wan Zamaniah Wan Ishak @ Wan Mohammad		 Role of Surgery and Symptom Management in Metastatic Lung Cancer
Dr Diong Nguk Chai 		Wellness: Cancer and Physical Activity: How Much is Enough?
Dr Ibrahim Ahmad Fuad
1715 - 1725 Q&A Q&A Q&A
1900 - 2200 CONGRESS DINNER (R.S.V.P ONLY)

SATURDAY, 27 September 2025

TIME BALLROOM 1
Room 301		 BALLROOM 2
 Room 302
 BALLROOM 3
Room 303		 Onco Exchange Foyer, Level 3 Onco Exchange Foyer, Level 3
0800 onwards REGISTRATION

 

 
0830 - 0900 Plenary Session 2
Chairpersons: Dr Chong Kwang Jeat & Dr Tang Shir Ley

AI in Oncology: Revolution or Illusion?
Dr Nesaretnam Barr Kumarakulasinghe
0900 - 0945

Tea Symposium by Servier

Chairperson:
Dr Natasha Mohd Hashim,
KPJ Johor Specialist Hospital

First-Line Treatment Strategies in Metastatic Pancreatic Cancer: Evolving Paradigm
Prof Dr Gerald Prager,
Medical University of Vienna, Austria

Case Presentation: Advancing Outcome in 1L mPaCa
Dr Yugarajah Asokumaran,
ONCOCARE Cancer Centre, Thomson Hospital

Tea Symposium by Zuellig Pharma

The Importance of Patient Selection in HR+HER2- High Risk EBC to Optimize Treatment and Reduce Recurrence with Abemaciclib

Chairperson:
Dr Lim Chun Sen,
Clinical Oncologist Gleneagles Medini, Johor Bahru

Speaker:
Prof Dr Lee Soo Chin,
Senior Consultant and Associate Director of Research at NCIS and Professor and Senior Principal Investigator at the Cancer Science Institute, National University of Singapore

Tea Symposium by Astellas Pharma Malaysia

Advancement in Metastatic Urothelial Cancer Care in Asia: The Role of Enfortumab vedotin and Pembrolizumab

Chairperson:
Prof Dr Marniza Saad

Speaker:
Prof Eiji Kikuchi,
St. Marianna University School
of Medicine
0945 - 1005 Break
1005 - 1110 Hepatobiliary
Chairpersons:
Dr Khairiyah Sidek & Dr Katherine Teh Hooi Lay		 Early Breast Cancer Chairpersons:
Dr Nur Fadhlina Abdul Satar & Dr Angel Kwan Khor Nee		 RTT
Chairpersons:
Mr Mohd Farihan Jaffar & Dr Noor Shatirah Mohd Fandi Voon		   Onco Exchange 2.1: Prostate
1005 - 1105

Chairperson:
Dr Ahmad Radzi
Ahmad Badruddin

Speakers:
Prof Dr Ravindran Kanesvaran, Assoc Prof Dr Marniza Saad, Assoc Prof Dr Melvin Chua 		  Onco Exchange 2.2: Lung
1005-1105

Chairperson:
Adj Prof Dr Voon Pei Jye

Speaker:
Prof Dr Samreen Ahmed
1005 - 1025 Downstaging Hepatocellular Carcinoma: Getting the Right Systemic Treatment Before Local Therapy
Clin Assoc Prof Dr David Tai Wai Meng		 De-escalation: Who Can Safely Receive Less Treatment?
Dr Kiley Loh Wei-Jen		 Abdominal Compression in managing respiratory motion during liver SBRT
Mr Mohd Khairul Mohd Zambri
1025 - 1045 Cutting-edge Development in Local Regional Therapy with Hepatocellular Carcinoma
Prof Dr Pierce Chow Kah-Hoe		 Escalation: Who Truly Needs Enhanced Treatment?
Dr Vaishnavi Jeyasingam		 Harnessing Technology and Human Touch: Future Directions for Radiation Therapists
Ms Nurul Fazreen Mohd Nadzri
1045 - 1105 Emerging Role of Biomarkers for Diagnosis and Therapeutic Options in Biliary Tract Cancer
Dr Wong Yoke Fui		 Challenges & Decision- Making in Post- Neoadjuvant Surgery
Prof Dr See Mee Hoong		 Enhancing Patient Accuracy with Surface-guided Radiotherapy techniques
Ms Farah Afrina Ismail
1105 - 1110 Q&A Q&A Q&A

 

 

 

TIME BALLROOM 1
Room 301		 BALLROOM 2
 Room 302
 BALLROOM 3
Room 303		 Onco Exchange Foyer, Level 3
1110 - 1225 Gyneoncology
Chairpersons:
Dr Prathepamalar Yehgambaram & Dr Rangasamy Ramachandran		 Advanced Breast Cancer Chairpersons:
Dr Natasha Mohd Hashim & Dr Cheo Seng Wee		 Physics
Chairpersons:
Dr Janatul Madinah Wahabi & Dr Jong Wei Loong

Onco Exchange 3: RTT
1115-1215

Chairpersons:
Mr Mohd Farihan Jaffar & Dr Noor Shatirah Mohd Fandi Voon

Speakers:
Mr Mohd Khairul Mohd Zambri, Mrs Nurul Fazreen Mohd Nadzri, Ms Farah Afrina Ismail
1110 - 1130 How Do I Treat Advanced Endometrial Cancer in 2026 Clin Asst Prof Jack Chan Junjie The Role of Antibody-Drug Conjugates (ADCs) in Metastatic HER2+ & HER2-Low Breast Cancer : Expanding the Role of ADCs – Where Do They Fit in Treatment Sequencing?
Dr Shaheenah Dawood		 AI Fundamentals for Medical Physicist
Dr Tan Li Kuo
1130 - 1150 HiPEC in Ovarian Cancer: Hope in the Heat
Prof Dr Myong Cheol Lim		 Endocrine Resistance in HR+/HER2- Advanced Breast Cancer: When to Switch or Intensify?
Dr Dejan Juric		 Treatment Plan Evaluation using Plan Complexity Metric
Ms Nur Diyana Afrina Mohd Hizam
1150 - 1210 Embrace vs Interlace :The Ultimate Showdown in Cervical Cancer Treatment
Asst Prof Dr Raviteja Miriyala		 MDT: Managing Oligometastatic Disease in Breast Cancer
Dr Mastura Md Yusof

Panel:Dr Kiley Loh, Prof DrSee Mee Hong, Dr Vaishnavi Jeyasingam		 Advancing Precision: VMAT Techniques for Craniospinal Irradiation
Ms Noor Naslinda Noor Rizan
1210 - 1225  Q&A  Q&A
1225 - 1325

Lunch Symposium by MSD

Uncovering New Approaches in the Management of Primary Advanced/Recurrent Endometrial Cancer

Chairperson:
Dr Cheah Soon Keat

 Speaker:
Dr John Chia

Lunch Symposium by Novartis

Breaking Barriers In Breast Cancer Care: The Future of HR+ HER2- Treatment

Chairperson:
Dr Yap Beng Khiong,
Consultant Clinical Oncologist, OncoCare Cancer Centre

 Speaker:
Dr Dejan Juric,
Director,Termeer Center for Targeted Therapies & Investigational Cancer Therapeutics Program, Massachusetts General Hospital Cancer Centre, U.S.A

Lunch Symposium by Roche

Redefining Lung Cancer Care with Tecentriq SC: World’s First Subcutaneous Immunotherapy

Chairperson:
Adj Prof Dr Voon Pei Jye,
Sarawak General Hospital, Kuching

Speakers:
Prof Dr Samreen Ahmed,
The University Hospitals of Leicester NHS Trust, UK

Dr Chong Kwang Jeat,
Mahkota Medical Centre, Melaka

Dr Mastura Md Yusof,
Hospital Picaso, Selangor

  
1325 - 1345 Break

 

TIME BALLROOM 1
Room 301		 BALLROOM 2
 Room 302
 BALLROOM 3
Room 303		 Onco Exchange Foyer, Level 3 Onco Exchange Foyer, Level 3
1345 - 1450 Kidney Debate: “To Cut or Not to Cut? The Fate of Cytoreductive Surgery in the Age of Immunotherapy!”
Chairpersons:
Dr Lim Chun Sen & Dr Daniel Gan Eng Hwee		 Biomarkers/ Genetics
Chairpersons:
Dr Ahmad Radzi Ahmad Badruddin & Mr Sayyidi Hamzi		 Nursing
Chairperson:
Ms Nor Zaipah Sulong		 Onco Exchange
4.1: Radiation of
Head & Neck
Cancers
1345 - 1445

Chairperson:
Assoc Prof Dr
Wan Zamaniah
Wan Ishak
@ Wan
Mohammad

Speakers:
Dr Sapna
Nangia,
Assoc Prof Dr
Gokula Kumar
Appalanaido		 Onco Exchange
4.2: GI
1345 - 1445

Chairperson:
Dr Ooi Kai Yun

Speaker:
Prof Dr Gerald
Prager
1345 - 1350 Case Presentation
Dr Tan Kee Nam		 Unlocking the Code to Personalised Cancer Care
Ms Jahnavi Kesavamatham		 Oncology Nurse Navigator
Ms Maheswari Jaganathan
1350 - 1405 Proposition
Dr Allen Sim Soon Phang
1405 - 1410 IInterpretation and Counselling for Genetic Testing - From the Common to the Rare Genes
Ms Yoon Sook Yee		 Cultural Sensitivity in Oncology Care – Addressing Diverse Patient Needs with Empathy
Ms Ho Sweet Lee
1410 - 1425 Opposition
Dr Peter Low Qin Jian
1425 - 1430 Cancer Genomics Research in Screening, Diagnosis and Therapeutics
Prof Dr Cheong Sok Ching		 Celebrating Patient Milestones – Bringing Joy to Oncology Care
Ms Azizan Mohd Isa
1430 - 1445  Discussion
1445 - 1450 Q&A Q&A    
1450 - 1535

Tea Symposium by IPSEN

Redefining First-Line Therapy in RCC : Long Term Outcomes of TKI + IO

Chairperson:
Assoc Prof Dr Marniza Saad, Universiti Malaya Medical Centre

Speakers:
Prof Dr Manuela Schmidinger, Austria
Dr Ng Hoong Hoong, Universiti Malaya

Tea Symposium by AstraZeneca

LAURA: Leading Advances and Unveiling Real Answers for UR Stage III EGFRm NSCLC

Chairperson:
Adj Prof Dr Voon Pei Jye

Speaker:
Dr Terufumi Kato, Director, Clinical Research and Trials Center, Physician, Division of Thoracic Oncology, Tokyo Metropolitan Komagome Hospital

Panelists:
Adj Prof Dr Voon Pei Jye & Prof Dr Ho Gwo Fuang

Tea Symposium by Rxillient Health Malaysia

Current IO Treatment Updates in Nasopharyngeal Carcinoma and Future Directions

Chairperson:
Dr Muthukkumaran Thiagarajan

Speaker:
Prof Dr Darren Lim, National Cancer Centre Singapore

    
1535 - 1555 Break Best Poster Presentation Award
Judging Session
1515 - 1615

Kindly refer to Top 10 Poster
Presentation Award Finalist page for breakdown

 

TIME BALLROOM 1
Room 301		 BALLROOM 2
 Room 302
 BALLROOM 3
Room 303
1555 - 1700 Prostate & Bladder
Chairpersons:
Dr Chong Chan Teng & Dr Yap Beng Khiong		 Immunotherapy/ADC
Chairpersons:
Dr Ahmad Radzi Ahmad Badruddin & Dr Ang Choon Seong		 Nursing
Chairperson:
Ms Nor Zaipah Sulong
1555 - 1615 Metastasis-Directed Therapy in Prostate Cancer: Game-Changer or Premature Gamble?
Assoc Prof Dr Melvin Chua		 Minimal Residual Disease
Prof Dr Ho Gwo Fuang		 Management of Stoma Care
Ms Mariam Mohd Nasir
1615 - 1635 Navigating New Frontiers: Recent Developments in Prostate Cancer Management
Prof Dr Ravindran Kanesvaran		 Science of ADC - Present and Future Challenges
Dr David Lee Dai Wee		 Understanding and Coping with Chemotherapy Side Effects
Ms Ong Yoke Ching
1635 - 1655 Smart Bombs Against Bladder Cancer: The Rise of Antibody-Drug Conjugates
Dr Yugarajah Asokumaran		 CAR T-cell in Solid Tumour
Dato' Dr Chang Kian Meng		 Recognising Early Sign of Immune- related Adverse Events and Toxicities from Targeted Therapies
Ms Latipah Abdul Wahab
1655 - 1700 Q&A Q&A Q&A
1700 - 1900 ANNUAL GENERAL MEETING (MOS MEMBERS ONLY)

SUNDAY, 28 September 2025

TIME BALLROOM 1
Room 301		 BALLROOM 2
 Room 302
 BALLROOM 3
Room 303		 Onco Exchange Foyer, Level 3
0800 onwards REGISTRATION
0830 - 0900 Plenary Session 3
Chairpersons: Dr Daniel Wong Wai Yan & Dr Izzati Wan Maharuddin

Beyond Cure: Addressing the Psychosocial Fallout in AYA Cancer Survivors
Dr Eileen Poon Yi Ling
0900 - 0945

Tea Symposium by Mega Bio-Life

Real-Word Retrospective Non Interventional Study with APRITANT IV Containing Regimen for Prophylaxis of CINV in Malaysian Subjects Receiving Moderately and Highly Emetogenic Chemotherapy

Chairperson:
Dr Chong Kwang Jeat
Clinical Oncologist, Mahkota Medical Centre, Melaka

Speaker:
Dr Sanjeev Chandran Joshi
Consultant Clinical Oncologist, Mahkota Medical Centre, Melaka

Tea Symposium by Medcin Phama

Spinery: Redefinitng Vertebral Metastases Management - One Ablation at a Time

Chairperson:
Dr Naveen Rajahdurai

Speaker:
Dr Mario Muto

Sessions taking place in Ballroom 1 & 2

  
0945 - 1005 Break
1005 - 1135 CNS
Chairpersons:
Dr Anbarasan Anbazagan & Dr Vickee Rajeswaran
 Turning the Tide on Liver Metastases - MDT Approach
Chairpersons:
Dr Audi Adawiah Sulaiman Shah & Dr Hayani Abdul Wahid		 Onco Rehab & Psychology
Chairpersons:
Dr Chiam Poh Jeann & Dr Yeo Geok Gee

Onco Exchange 5.1:
Nursing Workshop
1005 - 1135

Chairperson:
Mdm Siti Saadiah
Zainal Abidin

1000 - 1020
IM/SC
Ms Adele Woon Pei Ning

1025 - 1045
CHEMOPORT
Ms Rahayu
Ismail

1050 - 1105
PICC
Mdm Nurul Farhah
Zainudin

1110 - 1130
STOMACARE
Ms Nurbaisyah
Badaruddin
 1005 - 1025 Paediatric Medulloblastomas - A Crash Course for Clinical Oncologists
Dr Rasheila Ganapathi		 Liver Metastases: Navigating the Present Landscape
Dr Malwinder Singh Sandhu		 Psychosocial Interventions to Support Caregivers of Patients with Cancer
Dr Agnes Chong Shu Sze
 1025 - 1045 Treating Medulloblastomas in a Limited Resource Setting - Tips and Tricks
Dr Flora Chong Li Tze		 Lighting up Liver Metastases: Role of Nuclear Medicine
Dr Anthony Louis Anak Kindu		 Integrating Supportive Care Training for Future Professionals: the Right and Wrong Way of Communicating
Dr Nor Aniza Azmi
 1045 - 1105 Addressing Late Toxicities in Paediatric CNS RT
Dr Nisha Mohd Shariff		 Guided by Imaging, Driven by Precision: IR in Liver Metastases
 Dr Melisa Lim Seer Yee		 Head and Neck Cancer Rehabilitation
Dr Sharon Anne Khor
1105 - 1135 Q&A MDT (Liver Metastases): Cases Involving Oncologist, IR, Radiation Oncologist, Nuclear Physician, Surgeon Q&A

 

TIME BALLROOM 1
Room 301		 BALLROOM 2
 Room 302
 BALLROOM 3
Room 303
 1135 - 1250 Advanced Radiotherapy
Chairpersons:
Dr Najihah Abu Bakar & Dr Sandya Subramaniam		 Best Oral Presentation Award Judging Session
Chairpersons:
Dr Sri Kisha Subramaniam & Dr Chen May Feng		 Palliative & Hospice Care
Chairpersons:
Dr Aaron Hiew & Dr Kumutha Chalaya
 1135 - 1155 Proton Therapy in Paediatric CNS Tumours
Assoc Prof Dr Kanjana Shotelersuk		 1135-1150
The Effectiveness of the Echo Model for Patient Navigation Capacity Building in Malaysia
Dr Kishwani Hiram Chakraverty		 Advanced Care Planning (ACP) - From Theory to Practice : the Sabah Experience
Dr Ng Wan Jun
 1155 - 1215 Application of Proton Therapy for Head and Neck Cancers : Sharing of Evidence and Experience
Dr Sapna Nangia		 1150-1205
MRI-Based Radiomic Analysis for Local Recurrence Prediction in Head and Neck Squamous Cell Carcinoma Patients Undergoing Radiotherapy or Radiochemotherapy
Ms Wun Chin Leong		 Recognising the Right Time: Timely Palliative Care & Prognostification in Oncology
Dr Look Mei Ling
 1215 - 1235 Tongue HyBIRT : Brachytherapy Followed by IMRT in the Treatment of Tongue Cancer
Assoc Prof Dr Gokula Kumar Appalanaido		 1205-1220
Chemotherapy Plus Concurrent Irreversible Electroporation Improved Local Tumor Control in Unresectable Hilar Cholangiocarcinoma Compared with Chemotherapy Alone
Prof Dr Niu Lizhi		 Community Palliative Care & Domiciliary Service - Hospis Perspective
Ms Premala Ponnusamy
1235 - 1250 Q&A 1220-1245
Quantifying the Dosimetric Effect of Contrast-Enhanced CT in External Beam Radiotherapy Planning
Ms Nur Izyan Adhlin Sarudin		 Q&A
1250 - 1320 CLOSING CEREMONY

Social Events

DISCLAIMER: Whilst every attempt would be made to ensure all aspects of the conference mentioned in the Programme will take place as scheduled, the Organising Committee assumes no responsibility should it fail to materialize due to any unforeseen circumstances.

VIEW PROGRAMME IN PDF